Cryptosporidiosis in immunocompromised patients in the Islamic Republic of Iran

Journal of Microbiology, Immunology and Infection

Volumn 41, Issue 1, 2008, Pages 74-77

  Nahrevanian, Hossein ^a   Assmar, Mehdi ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Acquired immunodeficiency syndrome; Cryptosporidiosis; Cryptosporidium; Diarrhea; Immunologic deficiency syndromes; Iran; Leukemia, myeloid, acute

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; CHILD; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; DEATH; DIARRHEA; DISEASE DURATION; DRUG WITHDRAWAL; FECES ANALYSIS; FEMALE; FLUORESCENCE; HEALTH CENTER; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; IRAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; STAINING;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; CHILD; CHILD, PRESCHOOL; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; FECES; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INFANT, NEWBORN; IRAN; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED;

EID: 44849088796     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Marques FR, Cardoso LV, Cavasini CE, Almeida MC, Bassi NA, Almeida MT, et al. Performance of an immunoenzymatic assay for Cryptosporidium diagnosis of fecal samples. Braz J Infect Dis. 2005;9:3-5.
2. Xiao L, Fayer R, Ryan U, Upton SJ. Cryptosporidium taxonomy: recent advances and implications for public health. Clin Microbiol Rev. 2004;17:72-97.
3. Hunter PR, Nichols G. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev. 2002;15:145-54.
4. Clark DP. New insights into human cryptosporidiosis. Clin Microbiol Rev. 1999;12:554-63.
5. Makni F, Cheikrouhou F, Ayadi A. Parasitoses and immunodepression. Arch Inst Pasteur Tunis. 2000;77:51-4. [In French, English abstract].
6. Current L, Garcia LS. Cryptosporidiosis. Clin Microbiol Rev. 1991;4:325-58.
7. Leitch GJ, He Q. Arginine-derived nitric oxide reduces fecal oocyst shedding in nude mice infected with Cryptosporidium parvum. Infect Immun. 1994;62:5173-6.
8. Leitch GJ, He Q. Putative anticryptosporidial agents tested with an immunodeficient mouse model. Antimicrob Agent Chemother. 1994;38:865-7.
9. Leitch GJ, He Q. Reactive nitrogen and oxygen species ameliorate experimental cryptosporidiosis in the neonatal BALB/c mouse model. Infect Immun. 1999;67:5885-91.
10. Casemore DP, Sands RL, Currys IA. Cryptosporidium species a "new" human pathogen. J Clin Pathol. 1985;38: 1321-36.
11. Delaat AN. Microbiology for the allied health professions. 2nd ed. Philadelphia, USA: Lea & Febiger; 1979.
12. Nahrevanian H, Assmar M, Samin MG. Cryptosporidiosis among immunocompetent patients with gastroenteritis in Iran: a comparison with other enteropathogenic parasites. J Microbiol Immunol Infect. 2007;40:154-6.